跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,251 条关于
“Sumitomo Dainippon Pharma Oncology”
全部
19,251
临床试验
5,924
药物
1,261
机构
1,463
资讯
10,603
2个月前
Veristat Bolsters Leadership with Four Strategic Hires to Accelerate Novel Therapy Approvals in Cell and Gene Therapy, Oncology, and Rare Disease
2年前
FDA Accepts Sumitomo Pharma's sNDA for Vibegron in Men with OAB and BPH
去年
FDA Approves Gemtesa (Vibegron) for Overactive Bladder in Men with BPH
10个月前
Sumitomo Pharma Reports Promising Clinical Data for Enzomenib and Nuvisertib Ahead of ASH 2025
上个月
Sumitomo Pharma America Doses First Patient in Phase 1/2a Trial of iPSC-Derived Cell Therapy DSP-3077 for Retinitis Pigmentosa
3个月前
Delphia Therapeutics Appoints David Kerstein as CMO to Advance Novel Activation Lethality Cancer Platform
去年
AI-Designed Drug for Alzheimer's Psychosis Enters Clinical Trials
9年前
GSK Partners with Exscientia in £33M AI-Driven Drug Discovery Alliance
5年前
Exscientia Strengthens AI Drug Discovery Leadership with AstraZeneca Veteran as New CTO
16年前
Urovant Sciences Launches GEMTESA® (vibegron) for Overactive Bladder Treatment in the U.S.
第 1 页，共 1061 页
上一页
下一页
